Pharmaceutical Safety Review • Low Interaction Classification

L-Theanine vs Apigenin Prescription Drug Interactions & CYP450 Profile

Systematic analysis of cytochrome P450 enzyme metabolism, renal clearance competition, and clinical contraindications.

Absolute Clinical Contraindications

  • Concurrent prescription sedatives or benzodiazepines (additive depression)
  • Hypotension

Reported Clinical Adverse Events

  • Vivid dreams or nightmares (especially with high-dose L-theanine)
  • Mild morning grogginess if apigenin is dosed >100mg
  • Mild dizziness

Hepatic Cytochrome P450 (CYP) & Transporter Pathways

Compounds that modulate CYP3A4, CYP2D6, or P-glycoprotein (P-gp) can alter the bioavailability of concurrent medications including statins, anticoagulants, immunosuppressants, and blood pressure therapies:

  • CYP3A4 Substrate / Inhibitor: Potential competition with oral medications metabolized through hepatic CYP3A4 pathways.
  • Gastrointestinal Transit Modulation: GLP-1 receptor agonists and delayed-release botanicals slow gastric emptying, which may delay Tmax for orally administered therapeutics.
  • Pharmacokinetic Half-Life Clearance: Systemic clearance requires approximately 5 elimination half-lives (L-Theanine: 1 - 2 hours; Apigenin: approx. 12 hours).

Protocol Audit Links for L-Theanine vs Apigenin

← Return to L-Theanine vs Apigenin Monograph Calculate Weight Dosage Table → Launch Full Multi-Drug Interaction Checker →